Candidiasis, Vulvovaginal
Information
- Disease name
- Candidiasis, Vulvovaginal
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01293643 | Completed | Phase 3 | A Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077) | May 2010 | January 2011 |
| NCT01891331 | Completed | Phase 2 | A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidiasis (Yeast Infection) | August 2013 | December 2014 |
| NCT02180828 | Completed | Phase 4 | Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis | July 2014 | September 2015 |
| NCT02248506 | Completed | Phase 4 | Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis | June 2013 | March 2015 |
| NCT02251093 | Completed | Phase 3 | Study of the Efficacy and Tolerance of Intra-vaginal Treatment With a Total Freeze-dried Culture of Lcr Regenerans® in the Prevention of Relapses of Recurrent Vulvovaginal Candidiasis | May 2014 | |
| NCT02730494 | Completed | Phase 1 | Study Evaluating the Optimal Dosage for Equivalence Between Lcr Regenerans® Capsules and Tablets (Lactobacillus Rhamnosus Lcr35®) on the Vaginal Flora Colonisation | July 2015 | January 2018 |
| NCT02733432 | Completed | Phase 2 | RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections | June 8, 2016 | December 23, 2016 |
| NCT02888197 | Completed | Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization | August 16, 2016 | March 15, 2017 | |
| NCT02971007 | Completed | Phase 2 | Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) | November 2016 | May 2017 |
| NCT03975569 | Completed | N/A | Study of the Vaginal Microbiota and the Potential of a Vaginal Probiotic Cream in Vaginal Candidosis | April 4, 2016 | March 31, 2017 |
| NCT04626258 | Not yet recruiting | Phase 4 | Fluconazol Versus Medical Honey in the Treatment of Recurrent Vulvovaginal Candidiasis | March 1, 2021 | March 1, 2025 |
| NCT05367089 | Recruiting | Phase 3 | The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms | August 22, 2022 | April 22, 2027 |
| NCT03075046 | Recruiting | N/A | Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial | April 20, 2017 | December 2023 |
| NCT04930107 | Recruiting | Early Phase 1 | Vulvovaginal Candidiasis in Canadian Females | December 7, 2021 | April 30, 2026 |
| NCT05059145 | Recruiting | Phase 2 | A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis | April 27, 2022 | December 31, 2025 |
| NCT02859493 | Terminated | N/A | Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis | August 2016 | |
| NCT03167957 | Withdrawn | Phase 2 | Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis | December 2019 | December 2020 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D002181